⌘K
t
EKF Diagnostics Holdings plc announced on 19 May 2026 that all thirteen resolutions proposed at its Annual General Meeting (AGM) were duly passed. The voting results for the resolutions showed 'For' votes ranging from 82.54% to 99.99%.
| Date | 19 May 2026 |
| Time | 12:24:53 |
| Category | AGMs and other meetings |
| ID | 9450E |
EKF Diagnostics Holdings plc
("EKF" or the "Company")
Result of AGM and Voting Results
EKF Diagnostics Holdings plc (AIM: EKF), the AIM-listed global diagnostics business, announces that at its Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed.
The voting results of the AGM were as follows:
|
|
For |
Against |
Withheld |
||
|
Resolution |
Votes |
% |
Votes |
% |
Votes |
|
1 |
312,253,138 |
99.99% |
1,264 |
0.01% |
1,898,738 |
|
2 |
313,692,073 |
99.98% |
57,692 |
0.02% |
403,375 |
|
3 |
310,167,438 |
99.83% |
522,512 |
0.17% |
3,463,190 |
|
4 |
260,764,981 |
98.51% |
3,945,880 |
1.49% |
49,442,279 |
|
5 |
313,692,073 |
99.98% |
57,692 |
0.02% |
403,375 |
|
6 |
313,692,073 |
99.98% |
57,692 |
0.02% |
403,375 |
|
7 |
309,356,290 |
98.60% |
4,394,675 |
1.40% |
402,175 |
|
8 |
313,740,420 |
99.99% |
10,545 |
0.01% |
402,175 |
|
9 |
312,195,470 |
99.51% |
1,524,460 |
0.49% |
433,210 |
|
10* |
310,059,158 |
98.83% |
3,658,772 |
1.17% |
435,210 |
|
11* |
258,929,660 |
82.54% |
54,788,270 |
17.46% |
435,210 |
|
12* |
253,090,453 |
82.77% |
52,698,677 |
17.23% |
8,364,010 |
|
13 |
174,808,673 |
95.16% |
8,887,971 |
4.84% |
3,406,496 |
*denotes a Special Resolution
|
EKF Diagnostics Holdings plc |
||
|
Julian Baines, Executive Chair / Gavin Jones, Chief Executive Officer |
via Walbrook PR |
|
|
|
|
|
|
Singer Capital Markets (Nominated Adviser & Broker) |
Tel: +44 (0)20 7496 3000 |
|
|
Phil Davies / Patrick Weaver |
|
|
|
|
|
|
|
Walbrook PR Limited |
Tel: +44 (0)20 7933 8780 or ekf@walbrookpr.com |
|
|
Paul McManus / Alice Woodings |
Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 |
|
About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)
EKF is an AIM-listed global diagnostics business focussed on:
|
● |
Point-of-Care analysers in the key areas of Hematology and Diabetes |
|
● |
Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. |
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.